Versant Capital Management’s DexCom DXCM Stock Holding History

Versant Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Sell	2,369 -1,215	-34%	-$80.9K	0.01%	715
2026 Q1	$225K	Buy	3,584 +1,488	+71%	+$104K	0.02%	547
2025 Q4	$139K	Buy	2,096 +1,665	+386%	+$108K	0.02%	623
2025 Q3	$29K	Sell	431 -19	-4%	-$1.5K	﹤0.01%	1359
2025 Q2	$39.3K	Buy	+450	New	+$35.3K	0.01%	1112
2025 Q1	–	Sell	-321	Closed	-$25K	–	2554
2024 Q4	$25K	Buy	+321	New	+$23.8K	0.01%	918
2024 Q3	–	Sell	-40	Closed	-$4.54K	–	2035
2024 Q2	$4.54K	Hold	40	–	–	﹤0.01%	1254
2024 Q1	$5.55K	Hold	40	–	–	﹤0.01%	988
2023 Q4	$4.96K	Buy	40 +16	+67%	+$1.64K	﹤0.01%	965
2023 Q3	$2.24K	Buy	24 +4	+20%	+$451	﹤0.01%	1265
2023 Q2	$2.57K	Hold	20	–	–	﹤0.01%	1284
2023 Q1	$2.32K	Hold	20	–	–	﹤0.01%	1232
2022 Q4	$2.27K	Hold	20	–	–	﹤0.01%	1110
2022 Q3	$2K	Hold	20	–	–	﹤0.01%	1064
2022 Q2	$1K	Hold	20	–	–	﹤0.01%	1239
2022 Q1	$3K	Sell	20 -12	-38%	-$1.31K	﹤0.01%	1022
2021 Q4	$4K	Hold	32	–	–	﹤0.01%	949
2021 Q3	$4K	Hold	32	–	–	﹤0.01%	946
2021 Q2	$3K	Buy	32 +4	+14%	+$384	﹤0.01%	1031
2021 Q1	$3K	Buy	28 +8	+40%	+$751	﹤0.01%	1143
2020 Q4	$1K	Hold	20	–	–	﹤0.01%	1205
2020 Q3	$2K	Hold	20	–	–	﹤0.01%	1053
2020 Q2	$2K	Hold	20	–	–	﹤0.01%	1046
2020 Q1	$1K	Sell	20 -4	-17%	-$249	﹤0.01%	1127
2019 Q4	$1K	Hold	24	–	–	﹤0.01%	1218
2019 Q3	$0	Sell	24 -156	-87%	-$6.06K	﹤0.01%	1413
2019 Q2	$6K	Buy	180 +12	+7%	+$377	﹤0.01%	896
2019 Q1	$5K	Hold	168	–	–	﹤0.01%	1099
2018 Q4	$5K	Hold	168	–	–	﹤0.01%	1015
2018 Q3	$6K	Hold	168	–	–	﹤0.01%	1025
2018 Q2	$3K	Hold	168	–	–	﹤0.01%	1205
2018 Q1	$3K	Hold	168	–	–	﹤0.01%	1186
2017 Q4	$2K	Hold	168	–	–	﹤0.01%	1322
2017 Q3	$2K	Sell	168 -36	-18%	-$636	﹤0.01%	1242
2017 Q2	$3K	Buy	204 +36	+21%	+$665	﹤0.01%	1157
2017 Q1	$3K	Hold	168	–	–	﹤0.01%	1149
2016 Q4	$2K	Hold	168	–	–	﹤0.01%	1181
2016 Q3	$3K	Sell	168 -20	-11%	-$445	﹤0.01%	1087
2016 Q2	$3K	Hold	188	–	–	﹤0.01%	1067
2016 Q1	$3K	Hold	188	–	–	﹤0.01%	1046
2015 Q4	$3K	Buy	+188	New	+$3.91K	﹤0.01%	1040

Other funds holding DXCM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BIAS

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Versant Capital Management's DXCM Position: Q2 2026 in Review

Versant Capital Management reduced its DexCom (DXCM) stake by 34% in Q2 2026, selling an estimated $80.9K and leaving 2,369 shares worth $160K. The position accounts for 0.01% of the portfolio, ranked #715.

Versant Capital Management first reported a position in DXCM in Q4 2015 and has held it in 41 quarters since. The position peaked at $225K in Q1 2026. 122 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Versant Capital Management held 2,369 shares of DexCom worth $160K as of Q2 2026.
Versant Capital Management sold 1,215 DexCom shares in Q2 2026, an estimated $80.9K.
DexCom made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #715 holding.
Versant Capital Management first reported a position in DexCom in Q4 2015 and has held it in 41 quarters since.
Versant Capital Management's DexCom position peaked at $225K in Q1 2026.
122 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.